XyloCor Doses First Patient in Phase 2b Trial for XC001

Read More »

July 11, 2025

PharmaJet Partners with UPA, EVA Pharma for Egypt Vaccines

Read More »

July 11, 2025

EMA Grants Orphan Drug Status to Spinogenix’s SPG601 for Fragile X

Read More »

July 7, 2025

KalVista’s EKTERLY Approved by FDA as First Oral HAE Treatment

Read More »

July 7, 2025

Transition of Promotional Activities for Allergen Immunotherapy Drug Actair in Japan

Read More »

July 3, 2025

JCR Pharmaceuticals Completes Enrollment for JR-141 Phase III Trial

Read More »

July 3, 2025

Hikma Receives FDA Approval For TYZAVAN In The US

Read More »

July 2, 2025

Verrica, Torii Amend Deal to Launch Global Phase 3 Trial for YCANTH

Read More »

July 1, 2025

FDA Approves Expanded Use of GE’s Vizamyl for Alzheimer’s Care

Read More »

June 25, 2025

PharmaLogic Completes Acquisition of Majority Stake in Agilera Pharma AS

Read More »

June 23, 2025